Press Releases
Qihan Biotech Announces Appointment of Carl June to Scientific Advisory Board
December 2024
Qihan Biotech is proud to announce the appointment of Dr. Carl June as Cell Therapy Chair of its Scientific Advisory Board.
Qihan Biotech Announces NMPA Approval of Investigational New Drug (IND) Application for QN-019a, a Multi-locus Gene-Editing Cell Therapy Product to treat CD19-positive B-Cell Lymphoma
July 2023
Qihan Biotech announced today that the National Medical Products Administration (NMPA) approved its clinical trial application for the product QN-019a.
Qihan Biotech Appoints Tony W. Ho to its Board of Directors
October 2022
Qihan Biotech today announced the appointment of Tony W. Ho, M.D., to its Board of Directors as an independent director.
Media Coverage
January 2021
Timmerman Report
May 2022
VBDATA.CN
Publications